Published 11:48 IST, December 29th 2020
COVID-19: Novavax begins Phase 3 trials for its vaccine in US, Mexico
Final phase trials to determine the efficacy of a COVID-19 vaccine developed by Maryland based firm Novavax Inc. has begun in US and Mexico, NIH said.
null | Image:
self
Advertisement
Loading...
11:50 IST, December 29th 2020